Single-agent gemcitabine and gemcitabine/irinotecan combination (IrimoGem) in non-small cell lung cancer

C. M.S. Rocha Lima, J. R. Eckardt, S. S. Leong, C. A. Sherman, J. A. Perkel, T. Putman, A. R. Safa, H. R. Bahadori, M. R. Green

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint Dive into the research topics of 'Single-agent gemcitabine and gemcitabine/irinotecan combination (IrimoGem) in non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences